Skip to main content
GALECTIN THERAPEUTICS INC logo

GALECTIN THERAPEUTICS INC — Investor Relations & Filings

Ticker · GALT ISIN · US3632252025 LEI · 5299004HFYSAZM2ALW85 US Manufacturing
Open in API
Filings indexed 1,091 across all filing types
Latest filing 2011-04-11 Proxy Solicitation & In…
Country US United States of America
Listing US GALT

About GALECTIN THERAPEUTICS INC

https://galectintherapeutics.com/

Galectin Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapies for fibrotic diseases, chronic liver disease, and cancer. The company's therapeutic approach centers on inhibiting the galectin-3 protein, which is implicated in various inflammatory, fibrotic, and malignant conditions. Its lead drug candidate, belapectin (GR-MD-02), is a proprietary carbohydrate-based drug designed to bind to and inhibit galectin-3. The primary development program for belapectin is focused on treating non-alcoholic steatohepatitis (MASH) with cirrhosis, a serious liver disease with no currently approved therapies.

Recent filings

Filing Released Lang Actions
DEFINITIVE NOTICE & PROXY STATEMENT
Proxy Solicitation & Information Statement
2011-04-11 English
REVISED PRELIMINARY PROXY
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Schedule 14A filing, which is a Proxy Statement pursuant to Section 14(a) of the Securities Exchange Act of 1934. It is titled as a Revised Preliminary Proxy Statement for the 2011 Annual Meeting of Stockholders of Pro-Pharmaceuticals, Inc. The text includes detailed information about the meeting agenda, voting instructions, and proposals to be considered by shareholders, such as election of directors, amendments to compensation plans, and ratification of auditors. It is not the actual Annual Report or financial statements but rather the proxy solicitation materials sent to shareholders to inform and request their votes. This matches the definition of Proxy Solicitation & Information Statement (PSI). The document length is substantial (15,000 characters), indicating it is the full proxy statement, not just an announcement or notice. Therefore, the correct classification is PSI with high confidence.
2011-04-08 English
FORM 8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated March 31, 2011, reporting changes in employment agreements and the resignation of a CEO with related separation and consultancy agreements. The key section is Item 5.02, which covers departure and appointment of directors or certain officers and their compensation arrangements. There are no financial statements or earnings data presented, nor is this a full annual or quarterly report. The content focuses on management changes and employment contracts. According to the filing definitions, announcements of changes in the company's board of directors or senior management fall under Board/Management Information (MANG). Therefore, this document is best classified as MANG.
2011-04-06 English
PRELIMINARY PROXY STATEMENT
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Preliminary Proxy Statement filed under Schedule 14A pursuant to the Securities Exchange Act of 1934. It includes detailed information about the upcoming 2011 Annual Meeting of Stockholders, including proposals to be voted on, voting instructions, and other meeting-related information. The document is not a report of voting results, nor is it an announcement of a report publication. It is not an annual report or financial statement, but rather a solicitation of proxies for shareholder voting. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI). The document length is substantial (15,000 characters), indicating it is the full proxy statement, not just a brief announcement or notice.
2011-03-30 English
FORM 4
Director's Dealing
2011-03-28 English
FORM 4
Director's Dealing
2011-03-28 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.